Tartour E - Search Results

1

Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin.

Lee RS, Tartour E, van der Bruggen P, Vantomme V, Joyeux I, Goud B, Fridman WH, Johannes L. Lee RS, et al. Among authors: tartour e. Eur J Immunol. 1998 Sep;28(9):2726-37. doi: 10.1002/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.0.CO;2-W. Eur J Immunol. 1998. PMID: 9754560 Free article.

2

Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.

Sautès C, Mazières N, Galinha A, Tartour E, Bonnerot C, Amigorena S, Teillaud C, Spagnoli R, Fridman WH. Sautès C, et al. Among authors: tartour e. Immunol Res. 1992;11(3-4):181-90. doi: 10.1007/BF02919125. Immunol Res. 1992. PMID: 1287114 Review.

3

Current status of interleukin-2 therapy in cancer.

Tartour E, Mathiot C, Fridman WH. Tartour E, et al. Biomed Pharmacother. 1992;46(10):473-84. doi: 10.1016/0753-3322(92)90005-r. Biomed Pharmacother. 1992. PMID: 1306361 Review.

4

Soluble Fc gamma R (sFc gamma R): detection in biological fluids and production of a murine recombinant sFc gamma R biologically active in vitro and in vivo.

Sautès C, Teillaud C, Mazières N, Tartour E, Bouchard C, Galinha A, Jourde M, Spagnoli R, Fridman WH. Sautès C, et al. Among authors: tartour e. Immunobiology. 1992 Aug;185(2-4):207-21. doi: 10.1016/s0171-2985(11)80642-x. Immunobiology. 1992. PMID: 1452202 Review.

5

Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice.

Lynch A, Tartour E, Teillaud JL, Asselain B, Fridman WH, Sautès C. Lynch A, et al. Among authors: tartour e. Clin Exp Immunol. 1992 Feb;87(2):208-14. doi: 10.1111/j.1365-2249.1992.tb02976.x. Clin Exp Immunol. 1992. PMID: 1531189 Free PMC article.

6

A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor.

Bouchard C, Galinha A, Tartour E, Fridman WH, Sautès C. Bouchard C, et al. Among authors: tartour e. J Exp Med. 1995 Dec 1;182(6):1717-26. doi: 10.1084/jem.182.6.1717. J Exp Med. 1995. PMID: 7500016 Free PMC article.

7

[Immunotherapy of malignant diseases].

Dorval T, Michon J, Tartour E, Fridman WH. Dorval T, et al. Among authors: tartour e. Bull Cancer. 1995;82 Suppl 2:127s-138s. Bull Cancer. 1995. PMID: 7542946 Review. French.

8

Non-cytotoxic CD4 tumour-infiltrating lymphocytes induce responses in patients with metastatic renal cell carcinoma previously treated with interleukin-2.

Mathiot C, Thiounn N, Tartour E, Flam T, Peyret C, Joyeux I, Zerbib M, Brandely M, Debré B, Fridman WH. Mathiot C, et al. Among authors: tartour e. Eur J Cancer. 1995;31A(9):1551-2. doi: 10.1016/0959-8049(95)00235-b. Eur J Cancer. 1995. PMID: 7577091 No abstract available.

9

Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function.

Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, D'Enghien CD, Lee R, Debre B, Fridman WH. Tartour E, et al. Int J Cancer. 1995 Oct 9;63(2):205-12. doi: 10.1002/ijc.2910630210. Int J Cancer. 1995. PMID: 7591205

10

Lack of efficacy of low-dose subcutaneous recombinant interleukin-2 and interferon-alpha in the treatment of metastatic renal cell carcinoma.

Thiounn N, Mathiot C, Dorval T, Flam TA, Tartour E, Mosseri V, Zerbib M, Fridman WH, Debre B. Thiounn N, et al. Among authors: tartour e. Br J Urol. 1995 May;75(5):586-9. doi: 10.1111/j.1464-410x.1995.tb07412.x. Br J Urol. 1995. PMID: 7613793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters